Summary: Researchers have shown that circulating factors from young mice can rejuvenate the aged retina by reducing cellular senescence, lowering inflammation, and restoring mitochondrial function. Using heterochronic parabiosis and single-cell RNA sequencing, the study highlights adiponectin receptor 1 (AdipoR1) and its downstream AMPK signaling pathway as central mediators of retinal rejuvenation.
Pharmacological activation of AdipoR1 with the agonist AdipoRon reproduced these effects, improving retinal electrophysiology, enhancing mitochondrial health, and reversing markers of cellular aging in mouse models. These findings point to AdipoR1 as a promising therapeutic target for age-related retinal degeneration.
Key Facts:
- Youthful systemic factors: Exposure to young blood rejuvenates aged mouse retinas, improving function and reducing senescent cell burden.
- AdipoR1 and AMPK: AdipoR1 signaling and activation of AMPK are essential for reversing retinal aging and restoring mitochondrial quality control.
- Therapeutic potential: The orally available AdipoR1 agonist AdipoRon mimics rejuvenation effects and could become a treatment avenue for vision loss linked to aging.
Source: Neuroscience News
Overview
As populations age, age-related retinal degeneration increasingly threatens vision and quality of life. The retina is a layered neural tissue responsible for capturing light and relaying visual signals to the brain, and it is vulnerable to cumulative damage, oxidative stress, inflammation, and cellular senescence. Conditions such as age-related macular degeneration, diabetic retinopathy, and glaucoma are major causes of blindness worldwide, which motivates the search for mechanisms and therapies that preserve retinal health.
In a recent study, scientists used heterochronic parabiosis—pairing the circulatory systems of young and old mice—together with single-cell RNA sequencing to map age-associated transcriptomic changes across retinal cell types and to identify factors that reverse aging. Their experiments revealed that young systemic factors can restore retinal function and structure in aged animals, and pinpointed AdipoR1-AMPK signaling as a key molecular axis driving rejuvenation.
Aging Retina: Cellular Changes and Vulnerabilities
The retina contains neurons, glial cells, and the retinal pigment epithelium (RPE), all of which must coordinate to maintain vision. Single-cell transcriptomic profiling showed broad, cell type–specific changes with age. RPE cells, microglia, and retinal ganglion cells exhibited elevated oxidative stress markers, increased inflammatory gene expression, and upregulation of senescence markers such as p16. These senescent cells adopt a pro-inflammatory secretory phenotype that disturbs retinal homeostasis and accelerates degeneration.
Mitochondrial dysfunction emerged as a recurrent feature of aging retinas. Because mitochondria supply the energy required for photoreceptors and other retinal cells, their decline leads to reduced ATP production, increased reactive oxygen species, and impaired cellular repair processes—factors that contribute to functional loss.
Heterochronic Parabiosis Reveals Rejuvenating Circulating Factors
To test whether systemic signals can alter retinal aging, researchers joined young and old mice via heterochronic parabiosis. After two months of shared circulation, aged mice exposed to young blood showed notable improvements: stronger retinal electrophysiological responses, lower numbers of senescent cells, reduced neuroinflammation, and preserved retinal layer structure. Conversely, young mice exposed to aged blood displayed signs of accelerated retinal aging, underscoring the bidirectional influence of the systemic environment on retinal health.
Molecular analyses of rejuvenated retinas demonstrated restored mitochondrial function: improved membrane potential, enhanced removal of damaged mitochondria through mitophagy, and recovery of ATP generation. These mitochondrial improvements correlated with better cellular phenotypes and functional outcomes, highlighting mitochondrial health as a central target for reversing retinal aging.
AdipoR1: A Central Mediator of Retinal Rejuvenation
Integrative transcriptomic analysis identified adiponectin receptor 1 (AdipoR1) as a prominent receptor whose expression declines with age in retinal cells. AdipoR1 is implicated in metabolic regulation and photoreceptor maintenance. In aged retinas, reduced AdipoR1 was associated with impaired AMPK signaling, mitochondrial dysfunction, and elevated senescence. Exposure to young circulation restored AdipoR1 expression and activated AMPK, promoting energy balance and mitochondrial quality control.
These findings suggest that AdipoR1 functions as a molecular switch that links systemic cues to intracellular programs governing mitochondrial health and senescence in the retina.
AdipoRon Treatment Mimics Rejuvenation
To determine whether direct activation of AdipoR1 could reproduce the benefits of youthful blood, the team treated aged mice with AdipoRon, an orally available AdipoR1 agonist, for two months. Treated animals showed improved retinal electrophysiological function, reductions in senescence markers and inflammatory cytokines, and restored mitochondrial metrics including membrane potential and ATP production.
At the cellular level, AdipoRon promoted mitophagy and clearance of damaged mitochondria, supporting renewed energy production and cellular resilience. These outcomes indicate that pharmacological activation of AdipoR1 offers a practical therapeutic approach to prevent or reverse aspects of age-related retinal degeneration.
Implications and Next Steps
This study demonstrates that the aging retina retains plasticity and can be rejuvenated by systemic factors that restore mitochondrial function and reduce cellular senescence. AdipoR1 and its downstream AMPK pathway stand out as actionable targets for interventions aimed at preserving vision in older adults.
Future work will focus on translating these findings to human models, evaluating the safety and efficacy of AdipoR1 agonists in clinical settings, and identifying additional circulating factors that influence retinal aging. Broader implications extend beyond the eye: modulating the systemic milieu and key signaling pathways may offer new strategies to combat aging in multiple tissues.
A Vision for the Future
Protecting sight into advanced age remains a major public health goal. By revealing how youthful systemic factors and AdipoR1 signaling restore retinal function and mitochondrial health, this research opens the door to therapies that could help millions maintain vision and quality of life as they grow older.
Funding: This work was supported by the National Natural Science Foundation of China (824B2040 to Y.L.); National Key Research and Development Project of China (2020YFA0112701 to Y.Z.); Science and Technology Program of Guangzhou, China (202206080005 to Y.Z.); and China National Postdoctoral Program for Innovative Talents (BX20240440 to X.L.).
About this visual neuroscience research news
Author: Neuroscience News Communications
Source: Neuroscience News Communications
Contact: Neuroscience News Communications – Neuroscience News
Image: Image credited to Neuroscience News
Original Research: Open access. “Heterochronic parabiosis uncovers AdipoR1 as a critical player in retinal rejuvenation” by Yidan Liu et al., Science Advances.
Abstract
Heterochronic parabiosis uncovers AdipoR1 as a critical player in retinal rejuvenation
Aging causes structural and functional decline in the retina, but the molecular drivers are not fully understood. Combining heterochronic parabiosis with single-cell RNA sequencing, this study generated detailed transcriptomic profiles of young, aged, and heterochronic-paired murine retinas to identify anti-aging targets. Results show extensive transcriptional changes across retinal cell types with aging. Systemic factors from young mice reversed senescent phenotypes and rejuvenated aged retinas, while aged blood accelerated aging in young retinas. Integrative analysis highlighted AdipoR1 and downstream AMPK signaling as central to retinal rejuvenation. Treatment with the AdipoR1 agonist AdipoRon reversed key features of retinal aging by promoting mitochondrial function and restoring youthful cellular states, identifying AdipoR1 as a promising therapeutic target for retinal aging.